Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
https://spc.pt/wp-content/uploads/2025/08/Extended-Reduced-Dose-Apixaban-for-Cancer-Associated-Venous-Thromboembolism.pdf
Mariana Paiva | Cardiologia - ULS São João/Hosp. São João
Catarina Neves | Cardiologia - Instituto Português de Oncologia Coimbra
All content for Sociedade Portuguesa de Cardiologia is the property of Sociedade Portuguesa de Cardiologia and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
https://spc.pt/wp-content/uploads/2025/08/Extended-Reduced-Dose-Apixaban-for-Cancer-Associated-Venous-Thromboembolism.pdf
Mariana Paiva | Cardiologia - ULS São João/Hosp. São João
Catarina Neves | Cardiologia - Instituto Português de Oncologia Coimbra
How to measure clinical response to
treatment in ATTR-CM progressive
disease
Prof.ª Olga Azevedo
Prof. Mário Oliveira
Sociedade Portuguesa de Cardiologia
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
https://spc.pt/wp-content/uploads/2025/08/Extended-Reduced-Dose-Apixaban-for-Cancer-Associated-Venous-Thromboembolism.pdf
Mariana Paiva | Cardiologia - ULS São João/Hosp. São João
Catarina Neves | Cardiologia - Instituto Português de Oncologia Coimbra
